APOTEA logo

Apotea AB (publ) Stock Price

OM:APOTEA Community·SEK 7.6b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 31 Fair Values set on narratives written by author

APOTEA Share Price Performance

SEK 0
-119.28 (-100.00%)
SEK 90.00
Fair Value
SEK 0
-119.28 (-100.00%)
Price SEK 0

APOTEA Community Narratives

·
Fair Value SEK 90 19.9% undervalued intrinsic discount

Rising Online Pharmacy Demand And New Warehouse Capacity Will Support Long Term Earnings

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Fair Value
·
Fair Value SEK 94.41 23.6% undervalued intrinsic discount

Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
SEK 94.41
23.6% undervalued intrinsic discount
Fair Value
Revenue
7% p.a.
Profit Margin
5%
Future PE
30x
Price in 2030
SEK 124.01
SEK 90
19.9% undervalued intrinsic discount
Revenue
12.33% p.a.
Profit Margin
4.48%
Future PE
23.3x
Price in 2029
SEK 105.14

Trending Discussion

No trending discussion available.

Updated Narratives

APOTEA logo

Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions

Fair Value: SEK 94.41 23.6% undervalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
APOTEA logo

APOTEA: Share Program Reforms Will Support Higher Future Profitability

Fair Value: SEK 90 19.9% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with high growth potential.

0 Risks
2 Rewards

Apotea AB (publ) Key Details

SEK 7.6b

Revenue

SEK 6.1b

Cost of Revenue

SEK 1.5b

Gross Profit

SEK 1.3b

Other Expenses

SEK 245.7m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 05, 2026
2.36
19.85%
3.24%
0%
View Full Analysis

About APOTEA

Founded
2011
Employees
736
CEO
Par Svardson
WebsiteView website
www.apotea.se

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears. In addition, the company offers leasing and hiring out personnel to related companies, as well as marketing contributions. The company was founded in 2011 and is headquartered in Stockholm, Sweden.

Recent APOTEA News & Updates

Analysis Article Jul 22

Apotea AB (publ) Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

The second-quarter results for Apotea AB (publ) ( STO:APOTEA ) were released last week, making it a good time to...
Narrative Update Jun 26

APOTEA: Share Program Reforms Will Support Higher Future Profitability

Analysts have trimmed their Apotea price target from SEK 105 to SEK 90, citing updated assumptions that combine slightly lower revenue growth and a higher discount rate with expectations for a higher profit margin and a lower future P/E multiple. What’s in the News for Apotea At the Annual General Meeting on May 26, 2026, Apotea shareholders approved amendments to the articles of association that introduce two new share classes: D shares and S shares.

Recent updates

No updates